Making The Decision about Breast Implants
Should I get breast implants? Are there alternatives? Will they need to be replaced? No matter what your reason – medical or cosmetic – for getting breast implants, the subject can be confusing and even emotionally taxing. Here, experts from the federal Food and Drug Administration (FDA) tell you what you need to know both for an informed conversation with your doctor and an informed decision.
Know the Basics
The FDA has approved implants for increasing breast size in women, for reconstruction after breast cancer surgery or trauma, and to correct developmental defects. Implants are also approved to correct or improve the result of a previous surgery.
A number of studies have reported that a majority of breast augmentation and reconstruction patients are satisfied with the results of their surgery. The FDA has approved two types of breast implants for sale in the U.S.: saline (salt water solution)-filled and silicone gel-filled. Both have a silicone outer shell and vary in size, shell thickness and shape.
Know the Risks
Silicone implants sold in the U.S. are made with medical-grade silicone. These implants undergo extensive testing to establish reasonable assurance of safety and effectiveness. Nonetheless, there are risks associated with all breast implants, including:
*Capsular contracture—scar tissue that squeezes the implant
*Rupture (tears or holes in the shell) with deflation of saline-filled implants
*Silent (without symptoms) rupture of silicone gel-filled implants
FDA experts suggest five things women should know about breast implants.
1. Breast implants are not lifetime devices. The longer a woman has them, the greater the chances that she will develop complications, some of which will require more surgery. The patient can also request additional surgeries to modify the aesthetic outcome, such as size or shape.
“The life of these devices varies according to the individual,” says Gretchen Burns, a nurse consultant at FDA’s Center for Devices and Radiological Health (CDRH). “All women with implants will face additional surgeries—no one can tell them when.” While a few women have kept their original implants for 20-30 years, “that is not the common experience.”
2. You need to research products. Review the patient labeling. FDA advises that women look at the Summary of Safety and Effectiveness Data (SSED) for each implant to learn about their characteristics and the fillers used. SSEDs have been produced for all approved saline and silicone gel-filled breast implants. These summaries provide information on the indications for use, risks, warnings, precautions, and studies associated with FDA approval of the device. Look at the frequency of serious complications found in the SSED. The most serious are “those that lead to further surgeries, such as ruptures or capsular contracture,” says Tajanay Ki, a biomedical engineer in CDRH.
FDA advises health care providers to give women the full labeling—all of the patient information from the manufacturer—for an implant. Ask your surgeon for the most recent version of the labeling. You should have at least 1-2 weeks to review the information before making a decision, but with some reconstruction or revision surgery cases, it may be advisable to perform surgery sooner.
3. Communicate with the surgeon. Surgeons must evaluate the shape, size, surface texture and placement of the implant and the incision site for each woman. Ask the surgeon questions about his or her professional experience, the surgical procedure, and the ways the implant might affect an individual’s life.
Also, tell the surgeon about previous surgeries and your body’s response—for example, whether surgeries resulted in excessive scar tissue—and discuss your expectations. This helps the surgeon make operative decisions that achieve the desired appearance (i.e., incision location and size, implant size and placement). Many women undergo reoperation to change implant size. To achieve optimal results after the first procedure, careful planning and reasonable expectations are necessary.
4. Learn about long-term risks. Some women with breast implants have experienced connective tissue diseases, lactation difficulties or reproductive problems. However, current evidence does not support an association between breast implants and these conditions. FDA has identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin’s lymphoma. Women who have breast implants may have a very small but increased risk of developing ALCL in the fluid or scar tissue surrounding the implant. Like other lymphomas, ALCL is a cancer of the immune system and not of breast tissue.
5. Monitoring is crucial. FDA recommends that women with breast implants promptly report any unusual signs or symptoms to their health care providers, andreport any serious side effects to MedWatch, FDA’s safety information and adverse event reporting program.
Furthermore, women with silicone implants should get MRI screenings to detect silent ruptures three years after their surgery and every two years after that. Insurance may not cover these screenings. Burns recommends that women with breast implants continue to perform self-examinations and get mammograms to look for early signs of cancer. “Just because you have implants doesn’t mean you can ignore other breast health recommendations,” she says.
Reprinted courtesy of FDA Consumer Health Information. For additional resources, visit the FDA’s breast implants web page, www.fda.gov/breastimplants.You can find information about each specific product as well as questions to ask health care professionals and contact information for manufacturers of FDA-approved breast implants.